Immunoglobulin vs placebo
Mortality (any cause during hospitalisation or · children with respiratory syncytial virus infection
It is very uncertain whether summary of findings table ‐ Immunoglobulins changes mortality (any cause during hospitalisation or compared with placebo (very low certainty).
1 finding from 1 review
- Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection 2023 · Cochrane Headline outcomes onlyRR 0.87 [0.14, 5.27]4 studies · 309 participantsVery low